Abstract
Summary
LPI (LP Information)' newest research report, the “Gastrointestinal (GI) Stent Industry Forecast” looks at past sales and reviews total world Gastrointestinal (GI) Stent sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal (GI) Stent sales for 2023 through 2029. With Gastrointestinal (GI) Stent sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal (GI) Stent industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal (GI) Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal (GI) Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gastrointestinal (GI) Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal (GI) Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal (GI) Stent.
The global Gastrointestinal (GI) Stent market size is projected to grow from US$ 423.6 million in 2022 to US$ 581.4 million in 2029; it is expected to grow at a CAGR of 581.4 from 2023 to 2029.
United States market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gastrointestinal (GI) Stent players cover Boston Scientific, Cook Medical, ELLA-CS, ConMed, Gore Medical, Taewoong Medical, Hobbs Medical, C.R. Bard and Merit Endotek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal (GI) Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents
Segmentation by application
Biliary Disease
Colorectal Cancer
Stomach Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Cook Medical
ELLA-CS
ConMed
Gore Medical
Taewoong Medical
Hobbs Medical
C.R. Bard
Merit Endotek
Olympus America
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gastrointestinal (GI) Stent market?
What factors are driving Gastrointestinal (GI) Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastrointestinal (GI) Stent market opportunities vary by end market size?
How does Gastrointestinal (GI) Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Gastrointestinal (GI) Stent landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal (GI) Stent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Gastrointestinal (GI) Stent market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal (GI) Stent and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal (GI) Stent.
The global Gastrointestinal (GI) Stent market size is projected to grow from US$ 423.6 million in 2022 to US$ 581.4 million in 2029; it is expected to grow at a CAGR of 581.4 from 2023 to 2029.
United States market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gastrointestinal (GI) Stent is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gastrointestinal (GI) Stent players cover Boston Scientific, Cook Medical, ELLA-CS, ConMed, Gore Medical, Taewoong Medical, Hobbs Medical, C.R. Bard and Merit Endotek, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal (GI) Stent market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Biliary Stents
Duodenal Stents
Colonic Stents
Pancreatic Stents
Esophageal Stents
Segmentation by application
Biliary Disease
Colorectal Cancer
Stomach Cancer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
Cook Medical
ELLA-CS
ConMed
Gore Medical
Taewoong Medical
Hobbs Medical
C.R. Bard
Merit Endotek
Olympus America
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gastrointestinal (GI) Stent market?
What factors are driving Gastrointestinal (GI) Stent market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gastrointestinal (GI) Stent market opportunities vary by end market size?
How does Gastrointestinal (GI) Stent break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gastrointestinal (GI) Stent Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gastrointestinal (GI) Stent by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gastrointestinal (GI) Stent by Country/Region, 2018, 2022 & 2029
2.2 Gastrointestinal (GI) Stent Segment by Type
2.2.1 Biliary Stents
2.2.2 Duodenal Stents
2.2.3 Colonic Stents
2.2.4 Pancreatic Stents
2.2.5 Esophageal Stents
2.3 Gastrointestinal (GI) Stent Sales by Type
2.3.1 Global Gastrointestinal (GI) Stent Sales Market Share by Type (2018-2023)
2.3.2 Global Gastrointestinal (GI) Stent Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gastrointestinal (GI) Stent Sale Price by Type (2018-2023)
2.4 Gastrointestinal (GI) Stent Segment by Application
2.4.1 Biliary Disease
2.4.2 Colorectal Cancer
2.4.3 Stomach Cancer
2.5 Gastrointestinal (GI) Stent Sales by Application
2.5.1 Global Gastrointestinal (GI) Stent Sale Market Share by Application (2018-2023)
2.5.2 Global Gastrointestinal (GI) Stent Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gastrointestinal (GI) Stent Sale Price by Application (2018-2023)
3 Global Gastrointestinal (GI) Stent by Company
3.1 Global Gastrointestinal (GI) Stent Breakdown Data by Company
3.1.1 Global Gastrointestinal (GI) Stent Annual Sales by Company (2018-2023)
3.1.2 Global Gastrointestinal (GI) Stent Sales Market Share by Company (2018-2023)
3.2 Global Gastrointestinal (GI) Stent Annual Revenue by Company (2018-2023)
3.2.1 Global Gastrointestinal (GI) Stent Revenue by Company (2018-2023)
3.2.2 Global Gastrointestinal (GI) Stent Revenue Market Share by Company (2018-2023)
3.3 Global Gastrointestinal (GI) Stent Sale Price by Company
3.4 Key Manufacturers Gastrointestinal (GI) Stent Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal (GI) Stent Product Location Distribution
3.4.2 Players Gastrointestinal (GI) Stent Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gastrointestinal (GI) Stent by Geographic Region
4.1 World Historic Gastrointestinal (GI) Stent Market Size by Geographic Region (2018-2023)
4.1.1 Global Gastrointestinal (GI) Stent Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gastrointestinal (GI) Stent Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gastrointestinal (GI) Stent Market Size by Country/Region (2018-2023)
4.2.1 Global Gastrointestinal (GI) Stent Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gastrointestinal (GI) Stent Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gastrointestinal (GI) Stent Sales Growth
4.4 APAC Gastrointestinal (GI) Stent Sales Growth
4.5 Europe Gastrointestinal (GI) Stent Sales Growth
4.6 Middle East & Africa Gastrointestinal (GI) Stent Sales Growth
5 Americas
5.1 Americas Gastrointestinal (GI) Stent Sales by Country
5.1.1 Americas Gastrointestinal (GI) Stent Sales by Country (2018-2023)
5.1.2 Americas Gastrointestinal (GI) Stent Revenue by Country (2018-2023)
5.2 Americas Gastrointestinal (GI) Stent Sales by Type
5.3 Americas Gastrointestinal (GI) Stent Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal (GI) Stent Sales by Region
6.1.1 APAC Gastrointestinal (GI) Stent Sales by Region (2018-2023)
6.1.2 APAC Gastrointestinal (GI) Stent Revenue by Region (2018-2023)
6.2 APAC Gastrointestinal (GI) Stent Sales by Type
6.3 APAC Gastrointestinal (GI) Stent Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gastrointestinal (GI) Stent by Country
7.1.1 Europe Gastrointestinal (GI) Stent Sales by Country (2018-2023)
7.1.2 Europe Gastrointestinal (GI) Stent Revenue by Country (2018-2023)
7.2 Europe Gastrointestinal (GI) Stent Sales by Type
7.3 Europe Gastrointestinal (GI) Stent Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gastrointestinal (GI) Stent by Country
8.1.1 Middle East & Africa Gastrointestinal (GI) Stent Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gastrointestinal (GI) Stent Revenue by Country (2018-2023)
8.2 Middle East & Africa Gastrointestinal (GI) Stent Sales by Type
8.3 Middle East & Africa Gastrointestinal (GI) Stent Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal (GI) Stent
10.3 Manufacturing Process Analysis of Gastrointestinal (GI) Stent
10.4 Industry Chain Structure of Gastrointestinal (GI) Stent
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal (GI) Stent Distributors
11.3 Gastrointestinal (GI) Stent Customer
12 World Forecast Review for Gastrointestinal (GI) Stent by Geographic Region
12.1 Global Gastrointestinal (GI) Stent Market Size Forecast by Region
12.1.1 Global Gastrointestinal (GI) Stent Forecast by Region (2024-2029)
12.1.2 Global Gastrointestinal (GI) Stent Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastrointestinal (GI) Stent Forecast by Type
12.7 Global Gastrointestinal (GI) Stent Forecast by Application
13 Key Players Analysis
13.1 Boston Scientific
13.1.1 Boston Scientific Company Information
13.1.2 Boston Scientific Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.1.3 Boston Scientific Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Boston Scientific Main Business Overview
13.1.5 Boston Scientific Latest Developments
13.2 Cook Medical
13.2.1 Cook Medical Company Information
13.2.2 Cook Medical Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.2.3 Cook Medical Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cook Medical Main Business Overview
13.2.5 Cook Medical Latest Developments
13.3 ELLA-CS
13.3.1 ELLA-CS Company Information
13.3.2 ELLA-CS Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.3.3 ELLA-CS Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ELLA-CS Main Business Overview
13.3.5 ELLA-CS Latest Developments
13.4 ConMed
13.4.1 ConMed Company Information
13.4.2 ConMed Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.4.3 ConMed Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 ConMed Main Business Overview
13.4.5 ConMed Latest Developments
13.5 Gore Medical
13.5.1 Gore Medical Company Information
13.5.2 Gore Medical Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.5.3 Gore Medical Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Gore Medical Main Business Overview
13.5.5 Gore Medical Latest Developments
13.6 Taewoong Medical
13.6.1 Taewoong Medical Company Information
13.6.2 Taewoong Medical Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.6.3 Taewoong Medical Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Taewoong Medical Main Business Overview
13.6.5 Taewoong Medical Latest Developments
13.7 Hobbs Medical
13.7.1 Hobbs Medical Company Information
13.7.2 Hobbs Medical Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.7.3 Hobbs Medical Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hobbs Medical Main Business Overview
13.7.5 Hobbs Medical Latest Developments
13.8 C.R. Bard
13.8.1 C.R. Bard Company Information
13.8.2 C.R. Bard Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.8.3 C.R. Bard Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 C.R. Bard Main Business Overview
13.8.5 C.R. Bard Latest Developments
13.9 Merit Endotek
13.9.1 Merit Endotek Company Information
13.9.2 Merit Endotek Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.9.3 Merit Endotek Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merit Endotek Main Business Overview
13.9.5 Merit Endotek Latest Developments
13.10 Olympus America
13.10.1 Olympus America Company Information
13.10.2 Olympus America Gastrointestinal (GI) Stent Product Portfolios and Specifications
13.10.3 Olympus America Gastrointestinal (GI) Stent Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Olympus America Main Business Overview
13.10.5 Olympus America Latest Developments
14 Research Findings and Conclusion